Safety of Helicobacter pylori eradication therapy in patients with inflammatory bowel disease
Not Applicable
- Conditions
- Inflammatory bowel disease (Ulcerative colitis, Crohn's disease)
- Registration Number
- JPRN-UMIN000017105
- Lead Sponsor
- Osaka medical collage
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) The patient who is not infected by Helicobacter pylori 2) The patient who is not under remission stage of IBD 3) The patient who is required the change of treatment for IBD during observation period 4) The patient who has allergy for penicillin 5) The patient who has malignant disease 6) The patient who has been already eradicated Helicobacter pylori 7) The patient who dose not agree with this study 8) The patinets who are determiend not to be appropriate for this study
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method